CO4410184A1 - Benzamidinas sustituidas, su preparacion y preparados farmaceuticos que las contienen - Google Patents

Benzamidinas sustituidas, su preparacion y preparados farmaceuticos que las contienen

Info

Publication number
CO4410184A1
CO4410184A1 CO95030618A CO95030618A CO4410184A1 CO 4410184 A1 CO4410184 A1 CO 4410184A1 CO 95030618 A CO95030618 A CO 95030618A CO 95030618 A CO95030618 A CO 95030618A CO 4410184 A1 CO4410184 A1 CO 4410184A1
Authority
CO
Colombia
Prior art keywords
methyl
imino
amine
pct
phenoxymethyl
Prior art date
Application number
CO95030618A
Other languages
English (en)
Inventor
Ralf Anderskewitz
Kurt Schromm
Ernst-Otto Renth
Franz Birke
Armin Fugner
Heuer Hubert
Christopher Meade
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of CO4410184A1 publication Critical patent/CO4410184A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/62—Compounds containing any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylcarbamates
    • C07C271/64—Y being a hydrogen or a carbon atom, e.g. benzoylcarbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/12—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
    • C07C259/18—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to carbon atoms of six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

1. NUEVAS BENZAMIDINAS SUSTITUIDAS DE LA FORMULA FIGURA 1 EN QUE A REPRESENTA EL GRUPO -XSUB1-CSUBmHSUB2m-XSUB2- (m IGUAL 2 A 6) O FIGURA 2 X1 REPRESENTA 0, NH o NCHSUB3, X2 REPRESENTA 0, NH, NCHSUB3 o FIGURA 3 X3 REPRESENTA -X-CSUBnHSUB2n-; X4 REPRESENTA -CSUBnHSUB2n-X-(n=1 o 2, X=0, NH o NCHSUB3); R1 REPRESENTA OH, CN, CORSUB12, COORSUB12, COORSUB 12 y CHO; R2 REPRESENTA Br, Cl, F, CFSUB3, OH, ALQUILO C1-C6 CICLOALQUILO C5-C7, ARILO, O-ARILO, CHSUB2-ARILO, CRSUB5RSUB6-ARILO, C(CHSUB3)SUB2-RSUB7; ********PENDIENTE DIGITAR HOJA 50**********
CO95030618A 1994-07-13 1995-07-12 Benzamidinas sustituidas, su preparacion y preparados farmaceuticos que las contienen CO4410184A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4424713A DE4424713A1 (de) 1994-07-13 1994-07-13 Substituierte Benzamidine, ihre Herstellung und Verwendung als Arnzneistoffe

Publications (1)

Publication Number Publication Date
CO4410184A1 true CO4410184A1 (es) 1997-01-09

Family

ID=6523047

Family Applications (1)

Application Number Title Priority Date Filing Date
CO95030618A CO4410184A1 (es) 1994-07-13 1995-07-12 Benzamidinas sustituidas, su preparacion y preparados farmaceuticos que las contienen

Country Status (37)

Country Link
US (1) US5731332A (es)
EP (1) EP0770059B1 (es)
JP (1) JP2931410B2 (es)
KR (1) KR100421580B1 (es)
CN (1) CN1083830C (es)
AT (1) ATE178590T1 (es)
AU (1) AU700585B2 (es)
BG (1) BG62090B1 (es)
BR (1) BR9508374A (es)
CA (1) CA2194885C (es)
CO (1) CO4410184A1 (es)
CZ (1) CZ289376B6 (es)
DE (2) DE4424713A1 (es)
DK (1) DK0770059T3 (es)
EE (1) EE03311B1 (es)
ES (1) ES2131830T3 (es)
FI (1) FI970094A (es)
GR (1) GR3030043T3 (es)
HK (1) HK1011966A1 (es)
HR (1) HRP950365B1 (es)
HU (1) HU224823B1 (es)
IL (1) IL114571A (es)
MX (1) MX9700273A (es)
MY (1) MY117090A (es)
NO (1) NO307373B1 (es)
NZ (1) NZ287883A (es)
PE (1) PE32496A1 (es)
PL (1) PL179595B1 (es)
RO (1) RO118653B1 (es)
RU (1) RU2159228C2 (es)
SA (1) SA95160355B1 (es)
SK (1) SK281744B6 (es)
TW (1) TW555738B (es)
UA (1) UA45351C2 (es)
WO (1) WO1996002497A1 (es)
YU (1) YU48934B (es)
ZA (1) ZA955780B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6486181B1 (en) 1992-08-28 2002-11-26 City Of Hope Human leukocutye 12-lipoxygenase and its role in the pathogenesis of disease states
US6191169B1 (en) 1992-08-28 2001-02-20 City Of Hope Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
ES2208737T3 (es) * 1995-03-10 2004-06-16 Berlex Laboratories, Inc. Derivados de benzamidina, su preparacion y su utilizacion como anticoagulantes.
EP0743064A1 (en) * 1995-05-17 1996-11-20 Eli Lilly And Company Leukotriene antagonists for use in the treatment or prevention of alzheimer's disease
DE19636689A1 (de) 1996-09-10 1998-03-12 Boehringer Ingelheim Kg Neue Benzamidinderivate
DE19718334A1 (de) 1997-04-30 1998-11-05 Boehringer Ingelheim Pharma Neue Benzylaminderivate und Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
TW513402B (en) * 1997-05-30 2002-12-11 Daiichi Seiyaku Co Process for preparing 3-(7-amidino-2-naphthyl)-2-phenylpropionic acid derivatives
CA2303935A1 (en) * 1997-10-15 1999-04-22 City Of Hope 12(s)-hete receptor blockers
ID24720A (id) 1997-12-12 2000-08-03 Novartis Ag Senyawa amidino tersubstitusi dalam perawatan penyakit gangguan paru-paru kronis
DE19834713A1 (de) * 1998-07-31 2000-02-03 Boehringer Ingelheim Pharma Neue Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US6291531B1 (en) * 1999-10-07 2001-09-18 Boehringer Ingelheim Pharma Kg LTB4 antagonist, processes for the preparation thereof and its use as a pharmaceutical composition
DE10000907A1 (de) * 2000-01-12 2001-07-19 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Aryl-iminomethyl-carbaminsäureestern
US6417382B2 (en) 2000-01-12 2002-07-09 Boehringer Ingelheim Pharma Kg Process for preparing aryl-iminomethyl-carbamino acid esters
US6528491B2 (en) * 2000-10-24 2003-03-04 Boehringer Ingelheim Pharma Kg Pyranoside derivatives
CA2433451A1 (en) * 2001-01-16 2002-07-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of an ltb4 antagonist for the treatment and/or prevention of diseases caused by increased expression of mucin genes
IL159493A0 (en) * 2001-07-14 2004-06-01 Boehringer Ingeiheim Pharma Gm Pharmaceutical formulation containing an ltb4 antagonist
US20030119901A1 (en) * 2001-07-14 2003-06-26 Boehringer Ingelheim Pharma Kg Pharmaceutical formulation containing an LTB4 antagonist
EP1420773A1 (en) * 2001-08-31 2004-05-26 Neurochem (International) Limited Amidine derivatives for treating amyloidosis
RS20050390A (en) * 2002-11-26 2008-04-04 Boehringer Ingelheim Pharma Gmbh. & Co.Kg., Pharmaceutical composition comprising a ltb4 antagonist and a cox-2 inhibitor or a combined cox 1/2 inhibitor
DE10350528A1 (de) * 2003-10-29 2005-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Arzneimittelformulierung, enthaltend einen LTB4-Antagonisten, sowie Verfahren zu deren Herstellung und deren Verwendung
US7262223B2 (en) * 2004-01-23 2007-08-28 Neurochem (International) Limited Amidine derivatives for treating amyloidosis
CN103012200B (zh) * 2011-09-20 2014-12-17 北京大学 具有β-分泌酶抑制功能的化合物及其制备方法与应用
CN110869362A (zh) 2017-05-12 2020-03-06 国立研究开发法人理化学研究所 A类gpcr结合性化合物改性体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0518818A3 (en) * 1991-06-11 1993-04-28 Ciba-Geigy Ag Arylethers, their manufacture and use as medicament
ATE125791T1 (de) * 1991-06-11 1995-08-15 Ciba Geigy Ag Amidino-verbindungen, ihre herstellung und verwendung als arzneimittel.
US5451700A (en) * 1991-06-11 1995-09-19 Ciba-Geigy Corporation Amidino compounds, their manufacture and methods of treatment
PT902013E (pt) * 1992-02-05 2002-06-28 Boehringer Ingelheim Pharma Novos derivados amidina sua preparacao e utilizacao como medicamento com actividade antagonista de ltb4
US5455274A (en) * 1992-12-09 1995-10-03 Ciba-Geigy Corporation Hydroxyamidine derivatives

Also Published As

Publication number Publication date
FI970094A0 (fi) 1997-01-10
ATE178590T1 (de) 1999-04-15
RU2159228C2 (ru) 2000-11-20
MY117090A (en) 2004-05-31
US5731332A (en) 1998-03-24
KR100421580B1 (ko) 2004-07-31
JP2931410B2 (ja) 1999-08-09
GR3030043T3 (en) 1999-07-30
IL114571A0 (en) 1995-11-27
YU45295A (sh) 1997-12-05
HUT77220A (hu) 1998-03-02
CA2194885A1 (en) 1996-02-01
BR9508374A (pt) 1998-05-26
UA45351C2 (uk) 2002-04-15
NO970122D0 (no) 1997-01-10
CZ289376B6 (cs) 2002-01-16
SK1997A3 (en) 1997-08-06
CN1152304A (zh) 1997-06-18
AU700585B2 (en) 1999-01-07
NO307373B1 (no) 2000-03-27
ES2131830T3 (es) 1999-08-01
HRP950365B1 (en) 2000-04-30
FI970094A (fi) 1997-01-10
WO1996002497A1 (de) 1996-02-01
PE32496A1 (es) 1996-08-12
EP0770059B1 (de) 1999-04-07
RO118653B1 (ro) 2003-08-29
BG62090B1 (bg) 1999-02-26
SA95160355B1 (ar) 2005-06-13
NZ287883A (en) 1999-02-25
CA2194885C (en) 2006-04-25
IL114571A (en) 2003-09-17
KR970704675A (ko) 1997-09-06
PL179595B1 (pl) 2000-09-29
YU48934B (sh) 2002-12-10
JPH10502645A (ja) 1998-03-10
HU9700059D0 (en) 1997-02-28
HU224823B1 (en) 2006-02-28
EE03311B1 (et) 2000-12-15
PL318115A1 (en) 1997-05-12
DK0770059T3 (da) 1999-10-18
CZ6697A3 (cs) 1998-02-18
ZA955780B (en) 1996-01-15
HK1011966A1 (en) 1999-07-23
TW555738B (en) 2003-10-01
DE4424713A1 (de) 1996-01-18
CN1083830C (zh) 2002-05-01
NO970122L (no) 1997-01-10
DE59505600D1 (de) 1999-05-12
HRP950365A2 (en) 1997-08-31
MX9700273A (es) 1997-05-31
BG101105A (en) 1998-04-30
EP0770059A1 (de) 1997-05-02
AU2674295A (en) 1996-02-16
SK281744B6 (sk) 2001-07-10

Similar Documents

Publication Publication Date Title
CO4410184A1 (es) Benzamidinas sustituidas, su preparacion y preparados farmaceuticos que las contienen
FI972628A (fi) Uudet sulfonamidit
DK0790824T3 (da) 2,2-dichloralkancarboxylsyrer, fremgangsmåde til fremstilling deraf, lægemidler indeholdende disse og anvendelse af disse lægemidler til behandling af insulinresistens
FI962947A0 (fi) Vesiliukoisia sientenvastaisia atsoleja
DE69231445T2 (de) Triazole enthaltende antifungizide mittel
DK0766696T3 (da) Thiazolidinderivater, fremstilling af disse forbindelser og lægemidler indeholdende disse forbindelser
BR9509970A (pt) Composto
BR9307249A (pt) Composto processo para a preparação do mesmo composição fungicida e processo para o combate de fungos
DE69310904D1 (de) Verbrückte bis-aryl-carbinol-derivate, zusammensetzungen und ihre verwendung
HUT74712A (en) Chemical intermediates useful in agriculture
DE69523581D1 (de) Anti-helicobacter ester- oder carbamatderivate von azolonen
BR9510198A (pt) Composto azo pirazolona processo para a sua preparação e utilização do composto
ATE170850T1 (de) Aminoalkylsubstituierte 5-mercaptothiazole, ihre herstellung und verwendung
ES8203372A1 (es) Procedimiento de preparacion de amidinohidrazonas sustitui- das